MoneyWorks4Me

Kopran informs about presentation

11 Jun 2021 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Kopran has informed that it has enclosed presentation on Q4FY21 earning of the Company. A copy of the said presentation is also being uploaded on the Company's website www.kopran.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..